John Barlow has sat on advisory board panels and received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Mylan, Novartis and Sanofi/Aventis
Among these options, the incretin-based drugs GLP-1-RA and DPP4i (which we will collectively call GLP-1 M) are widely used
Highly recommend to anyone looking for a 1 stop shop to optimize their health
Watch-outs to know: The FDA has flagged serious side effects of CJC-1295, such as increased heart rate and a full-body vasodilatory reaction, meaning your blood vessels widen, which could present other concerns
Heres what GLP-1 does, step by step: In the brain: It tells you that you are getting full, so you slow down or stop eating